Maintenance therapy in ovarian cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference46 articles.
1. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.;Coleman;Lancet,2011
2. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.;Bookman;J Clin Oncol,2009
3. Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-OvarAIO and EBMT.;Mobus;J Clin Oncol,2007
4. Intraperitoneal cisplatin and paclitaxel in ovarian cancer.;Armstrong;N Engl J Med,2006
5. Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomized, controlled, open-label trial.;Katsumata;Lancet Oncol,2013
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer;Frontiers in Immunology;2023-10-23
2. The economic value of knowing BRCA status: BRCA testing for optimizing treatment in recurrent epithelial ovarian cancer;Expert Review of Pharmacoeconomics & Outcomes Research;2023-02-03
3. Olaparib as maintenance therapy and salvage therapy in recurrent ovarian cancer: The early experience in Taiwan;Taiwanese Journal of Obstetrics and Gynecology;2021-07
4. Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: Comparison of active surveillance and maintenance treatment;Cancer Treatment Reviews;2020-11
5. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma;Journal of Hematology & Oncology;2020-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3